FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
Promising
The Promising Role of CRISPR Technology
Recent advancements in genome editing technology have opened up new avenues in the fight against cancer. One such promising technology...
